Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

NCT01270035 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Adalimumab

Sponsor

Keio University

Collaborators

[object Object]